The economic impact of mental healthcare consumption before and after stroke in a cohort of stroke patients in the Netherlands:a record linkage study by van Eeden, M et al.
  
 
The economic impact of mental healthcare
consumption before and after stroke in a cohort of
stroke patients in the Netherlands
Citation for published version (APA):
van Eeden, M., van Mastrigt, G. A. P. G., Evers, S. M. A. A., van Raak, E. P. M., Driessen, G. A. M., &
van Heugten, C. M. (2016). The economic impact of mental healthcare consumption before and after
stroke in a cohort of stroke patients in the Netherlands: a record linkage study. BMC Health Services
Research, 16(1), [688]. https://doi.org/10.1186/s12913-016-1915-3
Document status and date:
Published: 13/12/2016
DOI:
10.1186/s12913-016-1915-3
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
RESEARCH ARTICLE Open Access
The economic impact of mental healthcare
consumption before and after stroke
in a cohort of stroke patients in the
Netherlands: a record linkage study
M. van Eeden1,2, G. A. P. G. van Mastrigt1, S. M. A. A. Evers1*, E. P. M. van Raak3, G. A. M. Driessen2
and C. M. van Heugten2,4
Abstract
Background: Post-stroke healthcare consumption is strongly associated with a mental health diagnosis. This study
aimed to identify stroke patients who utilised mental healthcare facilities, explored their mental healthcare
consumption pre-stroke and post-stroke, and examined possible predictors of costs incurred by mental healthcare
consumption post-stroke.
Methods: Three databases were integrated, namely the Maastricht University Medical Centre (MUMC) Medical
Administration, the Stroke Registry from the Department of Neurology at MUMC, and the Psychiatric Case Registry
South-Limburg. Patients from the MUMC who suffered their first-ever stroke between January 1 2000 and
December 31 2004 were included and their records were analysed for mental healthcare consumption from 5 years
preceding to 5 years following their stroke (1995–2009). Regression analysis was conducted to identify possible
predictors of mental healthcare consumption costs.
Results: A total of 1385 patients were included and 357 (25.8%) received services from a mental healthcare facility
during the 10-year reference period around their stroke. The costs of mental healthcare usage increased over time
and peaked 1 year post-stroke (€7057; 22% of total mental healthcare costs). The number of hospitalisation days
and mental healthcare consumption pre-stroke were significant predictors of mental healthcare costs. Explained
variances of these models (costs during the 5 years post-stroke: R2 = 15.5%, costs across a 10 year reference period:
R2 = 4.6%,) were low.
Conclusion: Stroke patients have a significant level of mental healthcare comorbidity leading to relatively high
mental healthcare costs. There is a relationship between stroke and mental healthcare consumption costs, but
results concerning the underlying factors responsible for these costs are inconclusive.
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Background
Chronic diseases, such as stroke, are by far the leading
cause of mortality and permanent disability worldwide.
Recent data from the World Health Organization (WHO)
indicate that worldwide 1 out of every 466 people suffer a
stroke each year (15 million in total) of which one third
dies and one-third is permanently disabled [1]. In 2012 in
the Netherlands, 1% of the population suffered from a
stroke and almost 7% of this group died due to stroke
complications [2]. As treatments for acute stroke advance,
the number of stroke survivors, and hence people living
with a permanent disability, is likely to increase in the
future.
Post-stroke healthcare consumption is strongly associ-
ated with a mental health diagnosis [3]. A prospective
study on the association between psychiatric and cognitive
symptoms post-stroke showed that patients with psychi-
atric symptoms after a stroke are at an increased risk of
developing cognitive deficits and a decline in cognitive
function, and are therefore more likely to use mental
healthcare facilities [4]. In addition, various studies have
found a high incidence of post-stroke depression leading
to increased mental healthcare consumption [5–8].
Not only is the impact of stroke on mental health
significant, the economic impact of stroke is also consid-
erable. Currently, approximately 3–4% of the total
healthcare budget in Western countries is spent on
stroke patients [9]. In the Netherlands, costs of general
mental healthcare increased from 5.9% (€2.6 billion) of
the total healthcare expenditures to 7.3% (€5.4 billion)
[10]. In 2001, Evers et al. explored the post-stroke use of
mental healthcare facilities in the Netherlands by con-
ducting a study in which two healthcare databases were
linked for the period from 1987 to 1995 [11]. They
showed that stroke and mental healthcare costs are signifi-
cantly related (1.3% of total mental healthcare costs were
induced by stroke patients), but that further research into
the predictors of stroke-related mental healthcare costs is
necessary.
Although recent evidence on stroke and mental health-
care costs is limited, there is a wide variety of studies on
stroke-related costs in terms of population, methods,
disease severity, cost categories and perspective [12].
Demographic, patient and stroke-specific characteris-
tics, such as age [13] sex [14], length of stay [14, 15],
country [16], Modified Ranking Scale (MRS) scores
[17], stroke type [16–18] and stroke severity [14] have
all proven to be significant predictors of stroke related
costs. In addition, potential risk factors for stroke such
as hypertension [19], diabetes [15, 19], and smoking
[19] were found to be significant predictors of stroke-
related costs. Biological characteristics such as heart
failure [14], hyponatraemia [15], and atrial fibrillation
[14], also appeared to be significant predictors of costs.
Due to the aging of the population and a growing
demand for stroke care, stroke-related healthcare costs
are likely to increase in the future. For governments, this
causes discrepancies between cutting stroke-related
healthcare costs on the one hand and dealing with the
increasing demand for stroke-related healthcare inter-
ventions on the other hand. Therefore, it is imperative
to gain more insights into the costs associated with
stroke, which can be used to make valid recommenda-
tions and suggestions for healthcare policy makers and
support them in their decisions to adopt or reject new
healthcare technologies. Over the last decade, evidence
of the costs incurred by mental healthcare consumption
related to stroke in the Dutch context has been limited.
And previous research concerning the Dutch context is
out-dated [9, 11], creating a strong need for up-to-date
evidence. In gathering this evidence, it would be helpful
to identify possible predictors for mental healthcare con-
sumption. The aim of this study was to identify stroke pa-
tients who use mental healthcare facilities, to explore this
consumption 5 years pre-stroke and 5 years post-stroke,
and to examine possible predictors of costs incurred by
mental healthcare consumption after a stroke.
Methods
Design
The current study is a record linkage study in which three
separate databases were integrated. The Medical Ethics
Committee of Maastricht University (METC AZM/UM)
approved the current study. Since this study used data
from registers and databases and did not involve inter-
action with patients, the METC AZM/UM confirmed that
no informed or written consent was necessary for this
study.
Setting
The current study took place in the city of Maastricht
(120,000 inhabitants), a relatively small city in the south of
the Netherlands (Limburg province), and its surrounding
area (80,000 inhabitants). The Maastricht University Med-
ical Centre (MUMC) is the only hospital in this catchment
area of 200,000 inhabitants with both a regional and a
top-referral care function. In the MUMC, all patients are
registered with an ICD-9 or an ICD-10 classification
(ICD: International Statistical Classification of Diseases
and Related Health Problems), depending on the year
of admission.
Databases
Three databases were integrated in this study: the
Maastricht University Medical Centre Medical Admin-
istration (MA), the Maastricht Stroke Registry (MSR)
and the Psychiatric Case Registry South-Limburg (PCR).
The MA is the primary registry of the MUMC, and all
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patients admitted to the hospital are registered with an
ICD-9 or an ICD-10 classification. The MSR is the pro-
spective database from the Department of Neurology at
the MUMC, which contains the clinical, functional and
outcome data from all adult stroke patients (over 18 years
of age) who have been treated by the department since
July 1 1987. The PCR has been used since 1981 as a pro-
spective registry for collecting data from all patients who
use mental healthcare facilities in the Maastricht region.
Demographic and patient characteristics such as age,
gender, living with a partner, and discharge location were
collected from the MA. The MSR and clinical records
were used to collect possible predictors for stroke-related
mental healthcare costs, such as type of stroke (ischaemic
or haemorrhagic; cortical or lacunar), Modified Ranking
Scale (MRS) score, history of Transient Ischaemic Attack
(TIA), hypertension, smoking, alcohol use and diabetes. In
addition, information on patient contact with mental
healthcare facilities in terms of day-treatment, clinical
and outpatient care, and assisted living, was derived
from the PCR.
Timeline and inclusion criteria
The year 2009 was the last year in which complete data
were available in the PCR database. Therefore, it was de-
cided to include adult patients with ICD-9 code 430-438
or ICD-10 code 160-169 who suffered a stroke between
January 1 2000 and December 31 2004, which allowed
us to analyse patient data from 1995 until 2009 (analyses
from 5 years before the first stroke case until 5 years
after the last stroke case). Patients were included if they
suffered their first ever stroke in the period between
2000 and 2004. Patients were excluded if they suffered
from recurrent stroke, a subarachnoid haemorrhage, a
TIA or another vascular non-stroke event such as an
asymptomatic carotid stenosis, if they appeared to live
outside the catchment area (based on area codes); and if
death occurred during hospital admission for the first-
ever stroke.
Linkage
The MA and MSR were linked which resulted in a
complete database of stroke patients who suffered their
first-ever stroke between January 1 2000 and December
31 2004. Based on patient characteristics, a unique an-
onymous code was constructed for each individual pa-
tient. Through these codes, patients from the stroke
databases were identified in and linked to the PCR
database. The linkage was based upon the first letter of
the family (maiden) name, gender and date of birth.
Experience from previous research with the PCR
showed that these identifiers gave the best linkage, by
minimising the chance of mistaken identity [20].
Cost analysis and valuation
Costs were calculated based on quantities derived from
the PCR. Four mental healthcare costs categories were
included: costs of day-treatment, costs within the clinical
setting, costs incurred in the outpatient clinic and costs
of assisted living. Costs of day-treatment are based on
the costs of a psychiatric treatment day in a university
hospital. Clinical setting costs consisted of the costs of
visits to a general psychiatric hospital, the psychiatric
department of a university hospital and the psychiatric
department of a nursing home. Outpatient clinic costs
were based on visits to the outpatient department of a
psychiatric or university hospital and contacts with a psy-
chotherapist. Costs of assisted living were valued as the
costs of assisted living arrangements, such as housekeep-
ing, meals, and other assistance as needed. The updated
Dutch manual for cost analysis in healthcare research was
used for the valuation of these healthcare costs [21].
Statistical analysis
The statistical package SPSS version 20 was used to
merge all databases and to conduct all analyses. Missing
data regarding resource use were handled through mul-
tiple imputations, a preferred technique for analysing
data sets with missing values. It involves replacing each
missing data point with a set of plausible values to gener-
ate complete data sets [22]. Independent samples T-test
and Chi Square Tests were used to explore differences
between the users of mental healthcare (PCR+) and nonu-
sers of mental healthcare (PCR-). Significance was deter-
mined at the 0.05 level. Cost data were skewed, and
therefore all cost values were logarithmically transformed
to achieve a more normal distribution and permit the use
of linear regression. A number of ‘0.00001’ was added to
all cost values to avoid zero values for log transformation
[23]. Two different linear regression models were con-
structed; one to estimate possible predictors of the
mental healthcare costs post-stroke (Model 1) and a
second model to identify possible predictors of the
mental healthcare costs in the 5 years pre-stroke and
the 5 years post-stroke (Model 2). To avoid over fitting
of the model, one independent variable was selected as
a predictor in the models for every ten patients who
were included. Variables were entered into a linear re-
gression analysis using backward stepwise selection, in
which variables were removed from the model based on
the probability of the likelihood statistics [23]. Selection of
the prediction variables was based on the results from pre-
vious research, where predictors of high (mental health-
care) costs in a stroke population were identified [14–19].
Included variables were: sex, age, living with partner, num-
ber of hospitalization days, discharge location, stroke type
(ischaemic or haemorrhagic, cortical or lacunar), Modified
Ranking Scale (MRS) score, hypertension, diabetes, alive
van Eeden et al. BMC Health Services Research  (2016) 16:688 Page 3 of 8
for at least 5 years post-stroke, and costs pre-stroke (last
predictor was only used in regression model 1). Binary
and continuous variables were included in the regression
analysis, and dummies were created for the categorical
variable discharge location (discharged to nursing home,
discharged to home and discharged to rehabilitation
centre). Due to the large amount of missing data, the vari-
ables TIA (yes/no), smoking (yes/no) and alcohol use (yes/
no) were excluded from the regression models to avoid
under fitting. These models were chosen, because they
provide the most valuable information for answering the
main research questions. Again, significance was deter-
mined at the 0.05 level.
Results
Subjects and selection
A total of 4143 patients who were given an ICD-9 or an
ICD-10 stroke-related classification, between January 1
2000 and December 31 2004, were identified in the MA.
Due to various reasons, 2968 patients were excluded,
leaving 1175 patients for this study. An additional 210,
mostly outpatient clinic patients were identified in the
MSR resulting in a total of 1385 patients who suffered a
first-ever stroke during the 2000–2004 period. Of this
group of patients, 25.8% (n = 357) received services from
a mental healthcare facility at any time within the 10-
year reference period (5 years pre-stroke, and 5 years
post-stroke). Further details are presented in Fig. 1.
Psychiatric case registry (PCR)
To examine differences, stroke patients who were identi-
fied in the PCR (n = 357), further referred to as PCR+, were
compared with patients who were not identified in the
PCR (n = 1028), further referred to as PCR-. Significantly
more patients were clinically admitted to the hospital in
the PCR+ group, on average 6.5% more (p = 0.022). Also,
patients in the PCR+ group spent on average four more
days (p = 0.000) in the hospital post-stroke, which is signifi-
cantly higher than those in the PCR- group. Further details
on the differences in demographic and stroke characteris-
tics between PCR+ and PCR- patients are presented in
Table 1.
Mental healthcare consumption
Figure 2 presents the average mental healthcare con-
sumption 5 years pre-stroke and 5 years post-stroke.
When comparing these periods, the costs of mental
healthcare usage were higher post-stroke, with a peak in
the first year post-stroke (€7057; 22% of total mental
healthcare costs post-stroke). Total costs in 5 years pre-
stroke were €9038 (with an average €1807 per patient
per year) and total costs in 5 years post stroke were
€31,966 (with an average €6393 per patient per year). In
total, these costs increased by €22,928 per patient from
the pre-stroke period to the post-stroke period. Day-
treatment costs increase on average by €308; clinical set-
ting costs increases on average by €21,734; outpatient
clinic costs increased on average by €227; and assisted liv-
ing costs increased on average by €660. Figure 2 also illus-
trates that there was an increase in mental healthcare
costs over the 5 years pre-stroke. From the first year to
the fifth year pre-stroke, the annual costs increased by
€2344. When looking at the 5 years post-stroke, the an-
nual costs decreased by €774, from €7057 in the first year
to €6284 in the fifth year post-stroke.
Figure 2 also shows that costs within the clinical setting
is by far the largest cost category, in both the 5 years pre-
stroke (69.8%) and the 5 years post-stroke (87.7%). A total
of 10,413 mental healthcare contacts took place during
the 5 years pre-stroke, of which 5316 (51.1%) can be
assigned to assisted living. In the 5 years post-stroke, a
total of 39,958 mental healthcare contacts took place, of
which 32,251 (80.7%) can be assigned to the assisted liv-
ing. In addition, the top 25% of patients (n = 90) with the
highest pre-stroke costs accounted for over 41% of the
total post-stroke costs.
Predictors of costs
Two regression models were built; one to identify possible
predictors for total mental healthcare costs post-stroke
Fig. 1 Identification of eligible patients with respect to the MUMC
Medical Administration (MA), Maastricht Stroke Registry (MSR) and
the Psychiatric Case Registry (PCR)
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(Table 2; model 1), and one for total costs pre- and post-
stroke (Table 3; model 2). A total of 229 patients were in-
cluded in both models. The R2 in model 1 was 0.155,
meaning that 15.5% of the total costs post-stroke can be
explained by the predictors included in the model. The re-
sults show that a higher age (p = 0.018, β =0.048) and
more hospitalization days (p = 0.025, β = 0.026) led to sig-
nificantly higher post-stroke costs. In addition, patients
who used mental healthcare facilities preceding their
stroke incurred significantly higher post-stroke costs (p =
0.000, β = 0.249) in comparison with patients without a
history of mental healthcare consumption.
In model 2, the R2 is 0.047, indicating that only 4.7%
of the variance of total pre- and post-stroke costs can be
explained by the independent variables. However, one
independent variable was significant at the p = 0.05 level.
If patients were living with a partner they incurred sig-
nificantly more costs (p = 0.039, β = 0.757) in compari-
son with patients who lived alone.
Discussion
This study was conducted because of the need for new,
up-to-date evidence regarding post-stroke mental
healthcare consumption related costs in the Netherlands.
The results of this study show that mental healthcare
costs increase in the years preceding a first-ever stroke
and that the majority of costs are incurred in the first
year post-stroke. The results of factors contributing most
to the high costs of stroke are inconclusive.
In this study, 25.8% (n = 357) of first-ever stroke survivors
used mental healthcare facilities within the reference period
of 10 years. On average, patients identified in the PCR
(PCR+) spent 4 days more in the hospital than patients not
identified in the PCR (PCR-). This might be explained by
the fact that mental health comorbidity during a stroke-
related hospital stay often leads to longer hospitalization.
Mental healthcare consumption costs incurred within the
clinical setting, outpatient costs, costs of day-treatment,
and costs of assisted living increase significantly after a
stroke. In general, costs increased from 5 years pre-stroke
to 5 years post-stroke with €22.928 per patient, with an
average total costs of €9038 in the 5 years pre-stroke and
€31,966 in the 5 years post stroke. The majority of these
costs were incurred in the clinical setting (87.7%). This is
significantly higher than what was found in previous re-
search [11], which showed an increase in costs of €1439.
This difference might be explained by the more detailed
registration and extensiveness of the databases included in
the current study, which also provides more up-to-date in-
formation. Furthermore, it is notable that mental healthcare
costs tend to increase during the 5 years leading up to the
stroke event. Previous research [11] indicated that pre-
stroke TIA might explain this trend, but our study could
not confirm these findings. However, we did find that over
41% of the post-stroke mental healthcare costs were in-
curred by only 90 patients (25%). Additionally, increasing
vascular complications leading up to the stroke event might
be associated with depressive symptoms, resulting in higher
mental healthcare consumption.
The results of the regression analyses show that age,
number of hospitalization days and pre-stroke mental
healthcare costs are significant predictors for post-stroke
mental healthcare costs, and patients who lived with a
partner incurred more mental healthcare costs both be-
fore and after they had a stroke. This is in line with pre-
vious research that showed that an age over 65 [13] and
a long hospital stay [14, 15] were predictive factors for
post-stroke costs. An explanation of why patients who
live with a partner incur more costs might be because
Table 1 Characteristics of patients identified in the Psychiatric
Case Registry versus patients not identified in the Psychiatric
Case Registry
PCR+
(n = 357)
PCR-
(n = 1028)
p-value†
Demographic characteristics n. n.
Mean age in years at
stroke onset (SD*)
357 69.0
(14.0)
1028 71.3
(12.1)
0.051
Gender (% male) 357 48.2 1028 49.1 0.762
Living with partner (%) 357 42.0 1028 42.4 0.903
Hospital admission
(% clinical)
357 75.1 1028 68.6 0.022‡
Hospitalization days
(SD)
320 19.2
(20.6)
856 15.2
(13.1)
0.000‡
Discharge location
Nursing home (%) 357 35.9 1028 33.7 0.376
Home (+ rehabilitation)
(%)
357 52.1 1028 54.0 0.631
Rehabilitation centre
(%)
357 4.2 1028 5.4 0.392
Stroke characteristics
Stroke type
(Ischaemic,%)
357 82.1 1028 85.3 0.148
MRSa score (SD) 331 3.3 (1.2) 938 3.2 (1.2) 0.103
History of TIAb (% yes) 357 9.5 1028 11.2 0.298
Hypertension, history/now
(% yes)
357 47.1 1028 51.3 0.143
Smoking, history/now
(% yes)
357 34.4 1028 28.2 0.063
Alcohol use, history/now
(% yes)
357 26.9 1028 21.4 0.072
Diabetes, history/now
(% yes)
357 17.8 1028 17.1 0.568
*SD standard deviation
aMRS Modified Ranking Scale
bTIA Transient Ischemic Attack
†Non-parametric Mann-Whitney test or Chi-Square test used to test for
significant differences between PCR+ and PCR-
‡Significant at the 0.05 level
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partners contribute to detecting symptoms of mental
health problems in their significant others. In contrast
with the current study, previous research found a variety
of significant predictors of stroke-related costs [14–19].
This suggests careful consideration of underlying fac-
tors for predicting stroke-related mental healthcare
costs. Furthermore, with regard to the upward trend of
mental healthcare consumption preceding stroke in the
Netherlands, the current study found similar results as
those found in previous research [11]. However, despite
the availability of more extensive information and vari-
ables from the data sources used, it remains unclear as
to whether hypertension or diabetes, for example, are
indicators for high mental healthcare costs pre- and
post-stroke.
Post-stroke mental healthcare costs of €22,928 per
patient for the 5 years following a stroke indicate sig-
nificant costs when looking at all stroke patients on a
national level. In the Netherlands, 83% of all clinical
hospitalizations of stroke patients are due to first-ever
strokes (corrected for mortality) [24]. Records show
that 46,897 stroke patients were yearly discharged in
2010, resulting in 38,925 (83%) patients clinically hospi-
talized with a first-ever stroke [24]. According to our
Fig. 2 Total average mental health care consumption (MHC) 5 years before, and 5 years after stroke, split out in four cost categories (n = 357)
Table 2 Predictors of total post-stroke mental healthcare costs (Model 1)
Predictorsa Level β p 95% Confidence Interval
Living with partner Yes/no 0.536 0.277 -0.433, 1.505
Age Continuous 0.048 0.018† 0.008, 0.087
Number of hospitalization days Continuous 0.026 0.025† 0.003, 0.049
Discharged to nursing home Yes/no 0.364 0.751 -1.891, 2.619
Discharged to home Yes/no 0.983 0.357 -1.196, 3.162
Stroke type Ischemic/haemorrhagic 0.342 0.607 -0.968, 1.653
Stroke location Left/right 0.506 0.267 -0.390, 1.403
MRS Continuous 0.390 0.540 -0.861, 1.641
Hypertension Yes/no -0.277 0.545 -1.180, 0.625
Diabetes Yes/no -0.587 0.290 -1.679, 0.504
Alive within 10-year ref/period Yes/no 0.956 0.060 -0.043, 1.954
Mental healthcare costs before stroke Continuous 0.249 0.000† 0.118, 0.380
Explained variance 0.155 (R2)
†Significant at the p = 0.05 level
aPredictors with only two levels or continuous predictors were included. Based on the likelihood method, the variable ‘sex’ was excluded
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study results, 25,8% of this group used mental health-
care facilities accounting for approximately €6939 per
stroke patient per year. This would result in €70 million
stroke-related mental healthcare costs on a yearly basis.
In 2010, the Dutch mental healthcare budget was €5.4
billion, which would amount to 1.3% of the annual
mental healthcare budget in the Netherlands in 2010.
Strengths and limitations
The linkage of three extensive, well-structured, pro-
spective, databases providing information on stroke pa-
tients and mental healthcare consumption over a
period of 10 years is considered to be a strength of this
study. Another strength of this study is that the over
fitting of the regression models was prevented by in-
cluding variables based on the probability of the likeli-
hood statistics [23]. Finally, the current study presents
results of the most recent data available in combination
with numerous possible predictors of stroke-related
mental healthcare costs.
The current study was also subject to some limitations.
First, this study is based on secondary data analysis using
three data sources, which all contained patients from the
same limited geographic area. Second, it did not include
biological characteristics as possible predictors for stroke-
related costs due to the unavailability of data. Previous re-
search found several biological characteristics, such as
heart failure, hyponatraemia, and atrial fibrillation to be
significant predictors of stroke-related costs. Therefore, it
would be interesting to include more possible predictors
in future analyses.
Conclusion
The main conclusion of the current study is that stroke
patients have a significant mental healthcare comorbid-
ity, leading to high post-stroke mental healthcare costs.
Where previous research in 2001 found that strokes
account for 1.3% of the total Dutch mental healthcare
budget, our study results show equal findings in 2010.
Although our study results and previous research show a
significant relationship between stroke and mental health-
care consumption, information concerning the underlying
factors responsible for these costs is inconclusive. Future
research should focus on different predictors of stroke-
related costs.
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on the likelihood method, excluded variables were: MRS, Hypertension
van Eeden et al. BMC Health Services Research  (2016) 16:688 Page 7 of 8
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Health Services Research, CAPHRI, Research School for Public
Health and Primary Care, Faculty of Health, Medicine and Life Sciences,
Maastricht University, P.O. Box 6166200, MD, Maastricht, The Netherlands.
2MHeNS, School for Mental Health & Neuroscience, Department of Psychiatry
& Psychology, Faculty of Health Medicine and Life Sciences, Maastricht
University, Maastricht, The Netherlands. 3Department of Neurology,
Maastricht University Medical Centre, Maastricht, The Netherlands.
4Department of Neuropsychology & Psychopharmacology, Faculty of
Psychology & Neuroscience, Maastricht University, Maastricht, The
Netherlands.
Received: 11 February 2016 Accepted: 9 November 2016
References
1. WHO. Health topics, Stroke, cerebrovascular accident. 2012. p. 2012.
2. Kompas N. Beroerte: Prevalentie, indicentie en sterfte naar leeftijd en
geslacht. 2010. p. 2013.
3. Ghose SS, Williams LS, Swindle RW. Depression and other mental health
diagnoses after stroke increase inpatient and outpatient medical utilization
three years poststroke. Med Care. 2005;43:1259–64.
4. Rasquin S, Lodder J, Verhey F. The association between psychiatric and
cognitive symptoms after stroke: A prospective study. Cerebrovasc Dis.
2005;19:309–16.
5. Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A. A comparative
study into the one year cumulative incidence of depression after stroke and
myocardial infarction. J Neurol Neurosurg Psychiatry. 2003;74:581–5.
6. De Wit L, Putman K, Baert I, Lincoln NB, Angst F, Beyens H, et al. Anxiety
and depression in the first six months after stroke. A longitudinal
multicentre study. Disabil Rehabil. 2008;30:1858–66.
7. Gainotti G, Azzoni A, Lanzillotta M, Marra C, Razzano C. Some preliminary
findings concerning a new scale for the assessment of depression and
related symptoms in stroke patients. Ital J Neurol Sci. 1995;16:439–51.
8. Wilkinson PR, Wolfe CD, Warburton FG, Rudd AG, Howard RS, Ross-Russell
RW, et al. A long-term follow-up of stroke patients. Stroke. 1997;28:507–12.
9. Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos
GA. Future costs of stroke in the netherlands: The impact of stroke services.
Int J Technol Assess Health Care. 2006;22:518–24.
10. Heijnen H, Beekman A, Verheul R, Dekker J. Totale uitgaven zorg in de
periode 2000-2010 in miljoen euro en aandeel per deelsector. 2013.
11. Evers SM, Driessen GA, Ament AJ. The use of mental health care facilities
after stroke. A cost analysis. Int J Technol Assess Health Care. 2002;18:33–45.
12. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-
level data: A critical review of the literature. Stroke. 2009;40:e18–23.
13. Huang YC, Hu CJ, Lee TH, Yang JT, Weng HH, Lin LC, et al. The impact
factors on the cost and length of stay among acute ischemic stroke. J
Stroke Cerebrovasc Dis. 2013;22:e152–8.
14. Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, et al.
Predictors of acute hospital costs for treatment of ischemic stroke in an
academic center. Stroke. 1999;30:724–8.
15. Chen CM, Chang CH, Hsu HC, Lin CH, Chen KH. Factors predicting the total
medical costs associated with first-ever ischeamic stroke patients transferred
to the rehabilitation ward. J Rehabil Med. 2015;47:120–5.
16. Caro JJ, Huybrechts KF, Kelley HE, Group ftSEA. Predicting treatment costs
after acute ischemic stroke on the basis of patient characteristics at
presentation and early dysfunction. Stroke. 2001;32:100–6.
17. Fattore G, Torbica A, Susi A, Giovanni A, Benelli G, Gozzo M, et al. The social
and economic burden of stroke survivors in italy: A prospective, incidence-
based, multi-centre cost of illness study. BMC Neurol. 2012;12:137.
18. Cipriano LE, Steinberg ML, Gazelle GS, Gonzalez RG. Comparing and
predicting the costs and outcomes of patients with major and minor stroke
using the boston acute stroke imaging scale neuroimaging classification
system. AJNR Am J Neuroradiol. 2009;30:703–9.
19. Aouinti S, Malouche D, Ouaili-Mallek H, Saidi O, Lassoued O, Hentati F,
et al. Predictive risk factors for increased direct medical cost of stroke
in tunisia. 2013.
20. Ytema S. Patterns of mental healthcare. Groningen: van Denderen B.V; 1994.
21. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor
kostenonderzoek. 2010. p. 126.
22. Sinharay S, Stern HS, Russell D. The use of multiple imputation for the
analysis of missing data. Psychol Methods. 2001;6:317–29.
23. McDonald JH. Handbook of biological statistics: Data transformations.
Sparky House Publishing, Baltimore; 2014.
24. Bots ML, van Dis I, Koopman C, Vaartjes I, Visseren FLJ. Hart- en vaatziekten
in nederland 2013, Cijfers of leefstijl, risicofactoren, ziekte en sterfte. 2013.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
van Eeden et al. BMC Health Services Research  (2016) 16:688 Page 8 of 8
